Pharma & Healthcare
Global Oncolytic Virus Market Research Report 2024
- Feb 19, 24
- ID: 52028
- Pages: 68
- Figures: 114
- Views: 14
An oncolytic virus is a virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles or virions to help destroy the remaining tumor. Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
The global Oncolytic Virus market was valued at US$ 17 million in 2023 and is anticipated to reach US$ 27 million by 2030, witnessing a CAGR of 6.8% during the forecast period 2024-2030.
To date, two genetically engineered oncolytic viruses have been approved for marketing as drugs. One is Oncorine (H101, the same construct as ONYX‐015),9 an E1B‐deleted adenovirus, which was approved in China for head and neck cancer and esophagus cancer in 2005. The use and clinical data of Oncorine is so far limited to China. The other is T‐Vec (talimogene laherparepvec, IMLYGIC, formerly OncoVEXGM‐CSF), which was approved for melanoma by the FDA in the USA in October 2015 and was subsequently approved in Europe in January 2016 and in Australia in May 2016. For developing product, there are 3 products in Phase 3, 8 products in Phase 2, 7 products in Phase 1 and 3 products in Preclinical. Market competition is intense. Amgen, Shanghai Sunway Biotech, Oncolytics Biotech, Viralytics, Transgene SA are the leading developers in the industry; with high investment in research marketing and they will monopoly position in the industry. Other players include Oncolys BioPharma, Targovax, PsiOxus Therapeutics, SillaJen Biotherapeutics, Sorrento Therapeutics, Lokon Pharma, Genelux Corporation, Vyriad, TILT Biotherapeutics and Cold Genesys, etc.
This report aims to provide a comprehensive presentation of the global market for Oncolytic Virus, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncolytic Virus.
Report Scope
The Oncolytic Virus market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oncolytic Virus market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oncolytic Virus companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen
Shanghai Sunway Biotech
Segment by Type
Imlygic
Oncorine
Others
Segment by Application
Melanoma
Other Cancers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oncolytic Virus companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Oncolytic Virus market was valued at US$ 17 million in 2023 and is anticipated to reach US$ 27 million by 2030, witnessing a CAGR of 6.8% during the forecast period 2024-2030.
To date, two genetically engineered oncolytic viruses have been approved for marketing as drugs. One is Oncorine (H101, the same construct as ONYX‐015),9 an E1B‐deleted adenovirus, which was approved in China for head and neck cancer and esophagus cancer in 2005. The use and clinical data of Oncorine is so far limited to China. The other is T‐Vec (talimogene laherparepvec, IMLYGIC, formerly OncoVEXGM‐CSF), which was approved for melanoma by the FDA in the USA in October 2015 and was subsequently approved in Europe in January 2016 and in Australia in May 2016. For developing product, there are 3 products in Phase 3, 8 products in Phase 2, 7 products in Phase 1 and 3 products in Preclinical. Market competition is intense. Amgen, Shanghai Sunway Biotech, Oncolytics Biotech, Viralytics, Transgene SA are the leading developers in the industry; with high investment in research marketing and they will monopoly position in the industry. Other players include Oncolys BioPharma, Targovax, PsiOxus Therapeutics, SillaJen Biotherapeutics, Sorrento Therapeutics, Lokon Pharma, Genelux Corporation, Vyriad, TILT Biotherapeutics and Cold Genesys, etc.
This report aims to provide a comprehensive presentation of the global market for Oncolytic Virus, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncolytic Virus.
Report Scope
The Oncolytic Virus market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oncolytic Virus market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oncolytic Virus companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen
Shanghai Sunway Biotech
Segment by Type
Imlygic
Oncorine
Others
Segment by Application
Melanoma
Other Cancers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oncolytic Virus companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncolytic Virus Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Imlygic
1.2.3 Oncorine
1.2.4 Others
1.3 Market by Application
1.3.1 Global Oncolytic Virus Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Melanoma
1.3.3 Other Cancers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncolytic Virus Market Perspective (2019-2030)
2.2 Oncolytic Virus Growth Trends by Region
2.2.1 Global Oncolytic Virus Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Oncolytic Virus Historic Market Size by Region (2019-2024)
2.2.3 Oncolytic Virus Forecasted Market Size by Region (2025-2030)
2.3 Oncolytic Virus Market Dynamics
2.3.1 Oncolytic Virus Industry Trends
2.3.2 Oncolytic Virus Market Drivers
2.3.3 Oncolytic Virus Market Challenges
2.3.4 Oncolytic Virus Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncolytic Virus Players by Revenue
3.1.1 Global Top Oncolytic Virus Players by Revenue (2019-2024)
3.1.2 Global Oncolytic Virus Revenue Market Share by Players (2019-2024)
3.2 Global Oncolytic Virus Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oncolytic Virus Revenue
3.4 Global Oncolytic Virus Market Concentration Ratio
3.4.1 Global Oncolytic Virus Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncolytic Virus Revenue in 2023
3.5 Oncolytic Virus Key Players Head office and Area Served
3.6 Key Players Oncolytic Virus Product Solution and Service
3.7 Date of Enter into Oncolytic Virus Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncolytic Virus Breakdown Data by Type
4.1 Global Oncolytic Virus Historic Market Size by Type (2019-2024)
4.2 Global Oncolytic Virus Forecasted Market Size by Type (2025-2030)
5 Oncolytic Virus Breakdown Data by Application
5.1 Global Oncolytic Virus Historic Market Size by Application (2019-2024)
5.2 Global Oncolytic Virus Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Oncolytic Virus Market Size (2019-2030)
6.2 North America Oncolytic Virus Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Oncolytic Virus Market Size by Country (2019-2024)
6.4 North America Oncolytic Virus Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oncolytic Virus Market Size (2019-2030)
7.2 Europe Oncolytic Virus Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Oncolytic Virus Market Size by Country (2019-2024)
7.4 Europe Oncolytic Virus Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oncolytic Virus Market Size (2019-2030)
8.2 Asia-Pacific Oncolytic Virus Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Oncolytic Virus Market Size by Region (2019-2024)
8.4 Asia-Pacific Oncolytic Virus Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oncolytic Virus Market Size (2019-2030)
9.2 Latin America Oncolytic Virus Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Oncolytic Virus Market Size by Country (2019-2024)
9.4 Latin America Oncolytic Virus Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncolytic Virus Market Size (2019-2030)
10.2 Middle East & Africa Oncolytic Virus Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Oncolytic Virus Market Size by Country (2019-2024)
10.4 Middle East & Africa Oncolytic Virus Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Detail
11.1.2 Amgen Business Overview
11.1.3 Amgen Oncolytic Virus Introduction
11.1.4 Amgen Revenue in Oncolytic Virus Business (2019-2024)
11.1.5 Amgen Recent Development
11.2 Shanghai Sunway Biotech
11.2.1 Shanghai Sunway Biotech Company Detail
11.2.2 Shanghai Sunway Biotech Business Overview
11.2.3 Shanghai Sunway Biotech Oncolytic Virus Introduction
11.2.4 Shanghai Sunway Biotech Revenue in Oncolytic Virus Business (2019-2024)
11.2.5 Shanghai Sunway Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncolytic Virus Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Imlygic
1.2.3 Oncorine
1.2.4 Others
1.3 Market by Application
1.3.1 Global Oncolytic Virus Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Melanoma
1.3.3 Other Cancers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncolytic Virus Market Perspective (2019-2030)
2.2 Oncolytic Virus Growth Trends by Region
2.2.1 Global Oncolytic Virus Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Oncolytic Virus Historic Market Size by Region (2019-2024)
2.2.3 Oncolytic Virus Forecasted Market Size by Region (2025-2030)
2.3 Oncolytic Virus Market Dynamics
2.3.1 Oncolytic Virus Industry Trends
2.3.2 Oncolytic Virus Market Drivers
2.3.3 Oncolytic Virus Market Challenges
2.3.4 Oncolytic Virus Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncolytic Virus Players by Revenue
3.1.1 Global Top Oncolytic Virus Players by Revenue (2019-2024)
3.1.2 Global Oncolytic Virus Revenue Market Share by Players (2019-2024)
3.2 Global Oncolytic Virus Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oncolytic Virus Revenue
3.4 Global Oncolytic Virus Market Concentration Ratio
3.4.1 Global Oncolytic Virus Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncolytic Virus Revenue in 2023
3.5 Oncolytic Virus Key Players Head office and Area Served
3.6 Key Players Oncolytic Virus Product Solution and Service
3.7 Date of Enter into Oncolytic Virus Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncolytic Virus Breakdown Data by Type
4.1 Global Oncolytic Virus Historic Market Size by Type (2019-2024)
4.2 Global Oncolytic Virus Forecasted Market Size by Type (2025-2030)
5 Oncolytic Virus Breakdown Data by Application
5.1 Global Oncolytic Virus Historic Market Size by Application (2019-2024)
5.2 Global Oncolytic Virus Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Oncolytic Virus Market Size (2019-2030)
6.2 North America Oncolytic Virus Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Oncolytic Virus Market Size by Country (2019-2024)
6.4 North America Oncolytic Virus Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oncolytic Virus Market Size (2019-2030)
7.2 Europe Oncolytic Virus Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Oncolytic Virus Market Size by Country (2019-2024)
7.4 Europe Oncolytic Virus Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oncolytic Virus Market Size (2019-2030)
8.2 Asia-Pacific Oncolytic Virus Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Oncolytic Virus Market Size by Region (2019-2024)
8.4 Asia-Pacific Oncolytic Virus Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oncolytic Virus Market Size (2019-2030)
9.2 Latin America Oncolytic Virus Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Oncolytic Virus Market Size by Country (2019-2024)
9.4 Latin America Oncolytic Virus Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncolytic Virus Market Size (2019-2030)
10.2 Middle East & Africa Oncolytic Virus Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Oncolytic Virus Market Size by Country (2019-2024)
10.4 Middle East & Africa Oncolytic Virus Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Detail
11.1.2 Amgen Business Overview
11.1.3 Amgen Oncolytic Virus Introduction
11.1.4 Amgen Revenue in Oncolytic Virus Business (2019-2024)
11.1.5 Amgen Recent Development
11.2 Shanghai Sunway Biotech
11.2.1 Shanghai Sunway Biotech Company Detail
11.2.2 Shanghai Sunway Biotech Business Overview
11.2.3 Shanghai Sunway Biotech Oncolytic Virus Introduction
11.2.4 Shanghai Sunway Biotech Revenue in Oncolytic Virus Business (2019-2024)
11.2.5 Shanghai Sunway Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Oncolytic Virus Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Imlygic
Table 3. Key Players of Oncorine
Table 4. Key Players of Others
Table 5. Global Oncolytic Virus Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Oncolytic Virus Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Oncolytic Virus Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Oncolytic Virus Market Share by Region (2019-2024)
Table 9. Global Oncolytic Virus Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Oncolytic Virus Market Share by Region (2025-2030)
Table 11. Oncolytic Virus Market Trends
Table 12. Oncolytic Virus Market Drivers
Table 13. Oncolytic Virus Market Challenges
Table 14. Oncolytic Virus Market Restraints
Table 15. Global Oncolytic Virus Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Oncolytic Virus Market Share by Players (2019-2024)
Table 17. Global Top Oncolytic Virus Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus as of 2023)
Table 18. Ranking of Global Top Oncolytic Virus Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Oncolytic Virus Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Oncolytic Virus Product Solution and Service
Table 22. Date of Enter into Oncolytic Virus Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Oncolytic Virus Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Oncolytic Virus Revenue Market Share by Type (2019-2024)
Table 26. Global Oncolytic Virus Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Oncolytic Virus Revenue Market Share by Type (2025-2030)
Table 28. Global Oncolytic Virus Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Oncolytic Virus Revenue Market Share by Application (2019-2024)
Table 30. Global Oncolytic Virus Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Oncolytic Virus Revenue Market Share by Application (2025-2030)
Table 32. North America Oncolytic Virus Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Oncolytic Virus Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Oncolytic Virus Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Oncolytic Virus Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Oncolytic Virus Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Oncolytic Virus Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Oncolytic Virus Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Oncolytic Virus Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Oncolytic Virus Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Oncolytic Virus Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Oncolytic Virus Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Oncolytic Virus Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Oncolytic Virus Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Oncolytic Virus Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Oncolytic Virus Market Size by Country (2025-2030) & (US$ Million)
Table 47. Amgen Company Detail
Table 48. Amgen Business Overview
Table 49. Amgen Oncolytic Virus Product
Table 50. Amgen Revenue in Oncolytic Virus Business (2019-2024) & (US$ Million)
Table 51. Amgen Recent Development
Table 52. Shanghai Sunway Biotech Company Detail
Table 53. Shanghai Sunway Biotech Business Overview
Table 54. Shanghai Sunway Biotech Oncolytic Virus Product
Table 55. Shanghai Sunway Biotech Revenue in Oncolytic Virus Business (2019-2024) & (US$ Million)
Table 56. Shanghai Sunway Biotech Recent Development
Table 57. Research Programs/Design for This Report
Table 58. Key Data Information from Secondary Sources
Table 59. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oncolytic Virus Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Oncolytic Virus Market Share by Type: 2023 VS 2030
Figure 3. Imlygic Features
Figure 4. Oncorine Features
Figure 5. Others Features
Figure 6. Global Oncolytic Virus Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Oncolytic Virus Market Share by Application: 2023 VS 2030
Figure 8. Melanoma Case Studies
Figure 9. Other Cancers Case Studies
Figure 10. Oncolytic Virus Report Years Considered
Figure 11. Global Oncolytic Virus Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Oncolytic Virus Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Oncolytic Virus Market Share by Region: 2023 VS 2030
Figure 14. Global Oncolytic Virus Market Share by Players in 2023
Figure 15. Global Top Oncolytic Virus Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Oncolytic Virus Revenue in 2023
Figure 17. North America Oncolytic Virus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Oncolytic Virus Market Share by Country (2019-2030)
Figure 19. United States Oncolytic Virus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Oncolytic Virus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Oncolytic Virus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Oncolytic Virus Market Share by Country (2019-2030)
Figure 23. Germany Oncolytic Virus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Oncolytic Virus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Oncolytic Virus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Oncolytic Virus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Oncolytic Virus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Oncolytic Virus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Oncolytic Virus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Oncolytic Virus Market Share by Region (2019-2030)
Figure 31. China Oncolytic Virus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Oncolytic Virus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Oncolytic Virus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Oncolytic Virus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Oncolytic Virus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Oncolytic Virus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Oncolytic Virus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Oncolytic Virus Market Share by Country (2019-2030)
Figure 39. Mexico Oncolytic Virus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Oncolytic Virus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Oncolytic Virus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Oncolytic Virus Market Share by Country (2019-2030)
Figure 43. Turkey Oncolytic Virus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Oncolytic Virus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Amgen Revenue Growth Rate in Oncolytic Virus Business (2019-2024)
Figure 46. Shanghai Sunway Biotech Revenue Growth Rate in Oncolytic Virus Business (2019-2024)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed
Table 1. Global Oncolytic Virus Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Imlygic
Table 3. Key Players of Oncorine
Table 4. Key Players of Others
Table 5. Global Oncolytic Virus Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Oncolytic Virus Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Oncolytic Virus Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Oncolytic Virus Market Share by Region (2019-2024)
Table 9. Global Oncolytic Virus Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Oncolytic Virus Market Share by Region (2025-2030)
Table 11. Oncolytic Virus Market Trends
Table 12. Oncolytic Virus Market Drivers
Table 13. Oncolytic Virus Market Challenges
Table 14. Oncolytic Virus Market Restraints
Table 15. Global Oncolytic Virus Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Oncolytic Virus Market Share by Players (2019-2024)
Table 17. Global Top Oncolytic Virus Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus as of 2023)
Table 18. Ranking of Global Top Oncolytic Virus Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Oncolytic Virus Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Oncolytic Virus Product Solution and Service
Table 22. Date of Enter into Oncolytic Virus Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Oncolytic Virus Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Oncolytic Virus Revenue Market Share by Type (2019-2024)
Table 26. Global Oncolytic Virus Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Oncolytic Virus Revenue Market Share by Type (2025-2030)
Table 28. Global Oncolytic Virus Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Oncolytic Virus Revenue Market Share by Application (2019-2024)
Table 30. Global Oncolytic Virus Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Oncolytic Virus Revenue Market Share by Application (2025-2030)
Table 32. North America Oncolytic Virus Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Oncolytic Virus Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Oncolytic Virus Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Oncolytic Virus Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Oncolytic Virus Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Oncolytic Virus Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Oncolytic Virus Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Oncolytic Virus Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Oncolytic Virus Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Oncolytic Virus Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Oncolytic Virus Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Oncolytic Virus Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Oncolytic Virus Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Oncolytic Virus Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Oncolytic Virus Market Size by Country (2025-2030) & (US$ Million)
Table 47. Amgen Company Detail
Table 48. Amgen Business Overview
Table 49. Amgen Oncolytic Virus Product
Table 50. Amgen Revenue in Oncolytic Virus Business (2019-2024) & (US$ Million)
Table 51. Amgen Recent Development
Table 52. Shanghai Sunway Biotech Company Detail
Table 53. Shanghai Sunway Biotech Business Overview
Table 54. Shanghai Sunway Biotech Oncolytic Virus Product
Table 55. Shanghai Sunway Biotech Revenue in Oncolytic Virus Business (2019-2024) & (US$ Million)
Table 56. Shanghai Sunway Biotech Recent Development
Table 57. Research Programs/Design for This Report
Table 58. Key Data Information from Secondary Sources
Table 59. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oncolytic Virus Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Oncolytic Virus Market Share by Type: 2023 VS 2030
Figure 3. Imlygic Features
Figure 4. Oncorine Features
Figure 5. Others Features
Figure 6. Global Oncolytic Virus Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Oncolytic Virus Market Share by Application: 2023 VS 2030
Figure 8. Melanoma Case Studies
Figure 9. Other Cancers Case Studies
Figure 10. Oncolytic Virus Report Years Considered
Figure 11. Global Oncolytic Virus Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Oncolytic Virus Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Oncolytic Virus Market Share by Region: 2023 VS 2030
Figure 14. Global Oncolytic Virus Market Share by Players in 2023
Figure 15. Global Top Oncolytic Virus Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Oncolytic Virus Revenue in 2023
Figure 17. North America Oncolytic Virus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Oncolytic Virus Market Share by Country (2019-2030)
Figure 19. United States Oncolytic Virus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Oncolytic Virus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Oncolytic Virus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Oncolytic Virus Market Share by Country (2019-2030)
Figure 23. Germany Oncolytic Virus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Oncolytic Virus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Oncolytic Virus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Oncolytic Virus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Oncolytic Virus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Oncolytic Virus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Oncolytic Virus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Oncolytic Virus Market Share by Region (2019-2030)
Figure 31. China Oncolytic Virus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Oncolytic Virus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Oncolytic Virus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Oncolytic Virus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Oncolytic Virus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Oncolytic Virus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Oncolytic Virus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Oncolytic Virus Market Share by Country (2019-2030)
Figure 39. Mexico Oncolytic Virus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Oncolytic Virus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Oncolytic Virus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Oncolytic Virus Market Share by Country (2019-2030)
Figure 43. Turkey Oncolytic Virus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Oncolytic Virus Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Amgen Revenue Growth Rate in Oncolytic Virus Business (2019-2024)
Figure 46. Shanghai Sunway Biotech Revenue Growth Rate in Oncolytic Virus Business (2019-2024)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232